Cohance Lifesciences Limited has informed the Exchange regarding Appointment of Mr. Sunil Kumar Singh, Chief Quality officer as Senior Management Personnel of the company w.e.f. January 19, 2026.
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Cohance Lifesciences Limited has informed the stock exchange about the appointment of Mr. Sunil Kumar Singh as Chief Quality Officer of the company. He has also been designated as Senior Management Personnel. The appointment is effective from January 19, 2026. The announcement was filed under Regulation 30 of the SEBI Listing Regulations, which covers key managerial and senior management changes.
This is a routine senior management appointment and is unlikely to have a material impact on the stock price. It signals continued strengthening of the company's quality leadership, which is relevant for a pharma/lifesciences firm.